Heart patients with a distressed personality reported worse health

People with a distressed (Type D) personality reported worse health than other patients after having devices implanted to ensure proper heart rhythm, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

Those reporting worse health within a year of having the internal defibrillators implanted were assessed before the procedure and found to have "Type D" , meaning they tend toward increased but don't share them with others due to fear of .

In a study of 383 patients in the Netherlands, researchers also found that all defibrillator (ICD) patients whose devices shocked their hearts back into normal rhythm within a year of the procedure reported poorer . ICDs monitor and deliver electrical shocks to restore normal rhythm when life-threatening occur.

Patients who had both a and whose defibrillators delivered a shock within the first year reported the worst health of all.

"The finding is important because it demonstrates that the trauma of experiencing the lifesaving shock isn't the only factor contributing to a patient's sense of his or her well-being and identifies a group of patients who may need additional care to improve survivability," said Susanne S. Pedersen Ph.D., lead author of the study and professor of cardiac psychology at Tilburg University and at the Thoraxcenter at Erasmus Medical Center in Rotterdam, the Netherlands. "If we only focus on patients who have received a shock, we risk under-diagnosing patients with distress and not providing them with the additional treatment they may need."

Participants in the study (79 percent men) answered questions to assess their health status and determine if they had a Type D personality.

The personality questionnaire required a response to statements such as "I often feel unhappy" or "I am a closed kind of person." Patients rated their health on a scale from 0 to 100 the day before their defibrillator was implanted and again at three, six and 12 months later. About 24 percent of the group had a Type D personality while 14 percent had experienced a shock within the first year.

Other findings about how patients rated their health:

  • Patients who received a shock during the first year rated their physical and mental health 3 to 13 points lower than those who didn't.
  • Patients with Type D traits scored themselves 2 to 8 points lower than others.
  • Patients who had both Type D personality traits and had received a shock scored themselves up to 30 points lower than others.
Researchers did not have information about any changes in medications during the 12-month study period that may have influenced patients' health.

Pedersen said similar results would be expected among American patients but said the study should be repeated as defibrillators may be programmed more conservatively in the United States leading to differences in the number of shocks that patients may experience in Europe and in the United States.

add to favorites email to friend print save as pdf

Related Stories

Type D personality associated with higher future heart risk

Sep 14, 2010

Heart patients with the "distressed" (Type D) personality profile may face a higher risk of future cardiovascular problems, according to a summary article published in the American Heart Association journal Circulation: Ca ...

Recommended for you

Exercise may protect older women from irregular heartbeat

2 hours ago

Increasing the amount or intensity of physical activity can cut the chances of older women developing a life-threatening irregular heartbeat, according to new research in the Journal of the American Heart Association (JAHA).

Huge discrepancies on heart disease in Europe

13 hours ago

Russians and Ukrainians aged 55 to 59 die from coronary heart disease at a higher rate than Frenchmen who are 20 years older, a study released Wednesday of Europe's cardiovascular health showed.

Common antibiotic linked with heart deaths

23 hours ago

The antibiotic clarithromycin—widely used for treating common bacterial infections—is associated with an increased risk of heart deaths, finds a study published in the BMJ today.

User comments